Novel motif:138: Difference between revisions
From FANTOM5_SSTAR
(Created page with "{{Novel_motif
|name=motif138_CTTTWANNYCC
|novel_motifs_human_sample_pval=11376-118A8_11051;0.185789,11327-117E4_11969;0.394646,11473-119C6_11054;0.167338,11474-119C7_12067;0...") |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 15:17, 9 September 2013
name: | motif138_CTTTWANNYCC |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0042137 | sequestering of neurotransmitter | 2.688335e-18 |
GO:0016477 | cell migration | 8.204490e-11 |
GO:0006928 | cellular component movement | 8.389849e-10 |
GO:0044341 | sodium-dependent phosphate transport | 1.325896e-9 |
GO:0032908 | regulation of transforming growth factor beta1 production | 6.451633e-9 |
GO:0031915 | positive regulation of synaptic plasticity | 7.626818e-9 |
GO:0048870 | cell motility | 1.649507e-8 |
GO:0032914 | positive regulation of transforming growth factor beta1 production | 2.075403e-8 |
GO:0040011 | locomotion | 2.776102e-8 |
GO:0070302 | regulation of stress-activated protein kinase signaling cascade | 2.781795e-8 |
GO:0070304 | positive regulation of stress-activated protein kinase signaling cascade | 3.563631e-8 |
GO:0006707 | cholesterol catabolic process | 5.123914e-8 |
GO:0042534 | regulation of tumor necrosis factor biosynthetic process | 5.963443e-8 |
GO:0071460 | cellular response to cell-matrix adhesion | 8.147122e-8 |
GO:0032891 | negative regulation of organic acid transport | 1.332823e-7 |
GO:0009313 | oligosaccharide catabolic process | 1.917567e-7 |
GO:0048676 | axon extension involved in development | 1.941224e-7 |
GO:0040007 | growth | 2.667906e-7 |
GO:0002687 | positive regulation of leukocyte migration | 2.874986e-7 |
GO:0006689 | ganglioside catabolic process | 3.051053e-7 |
GO:0061029 | eyelid development in camera-type eye | 3.442413e-7 |
GO:0006605 | protein targeting | 4.933405e-7 |
GO:0051179 | localization | 5.144366e-7 |
GO:0016125 | sterol metabolic process | 5.343923e-7 |
GO:0051895 | negative regulation of focal adhesion assembly | 7.922184e-7 |
GO:0030225 | macrophage differentiation | 8.003059e-7 |
GO:0002685 | regulation of leukocyte migration | 1.122415e-6 |
GO:0008203 | cholesterol metabolic process | 1.197065e-6 |
GO:0045766 | positive regulation of angiogenesis | 1.367710e-6 |
GO:0071229 | cellular response to acid | 1.764818e-6 |
GO:0010758 | regulation of macrophage chemotaxis | 1.777213e-6 |
GO:0071281 | cellular response to iron ion | 1.911919e-6 |
GO:0048589 | developmental growth | 1.974887e-6 |
GO:0080135 | regulation of cellular response to stress | 2.017913e-6 |
GO:0002690 | positive regulation of leukocyte chemotaxis | 2.075199e-6 |
GO:0051915 | induction of synaptic plasticity by chemical substance | 2.161761e-6 |
GO:0044140 | negative regulation of growth of symbiont on or near host surface | 2.318330e-6 |
GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process | 2.591867e-6 |
GO:0045727 | positive regulation of translation | 2.708611e-6 |
GO:0046328 | regulation of JNK cascade | 2.734788e-6 |
GO:0010759 | positive regulation of macrophage chemotaxis | 2.960450e-6 |
GO:0050900 | leukocyte migration | 2.964258e-6 |
GO:0043200 | response to amino acid stimulus | 2.988235e-6 |
GO:0071295 | cellular response to vitamin | 3.035306e-6 |
GO:0006706 | steroid catabolic process | 3.469946e-6 |
GO:0043004 | cytoplasmic sequestering of CFTR protein | 4.095426e-6 |
GO:0046032 | ADP catabolic process | 4.195160e-6 |
GO:0046709 | IDP catabolic process | 4.195160e-6 |
GO:0071299 | cellular response to vitamin A | 4.268170e-6 |
GO:0043201 | response to leucine | 4.296322e-6 |
GO:0010746 | regulation of plasma membrane long-chain fatty acid transport | 4.821557e-6 |
GO:0002448 | mast cell mediated immunity | 4.927471e-6 |
GO:0015827 | tryptophan transport | 5.122051e-6 |
GO:0032103 | positive regulation of response to external stimulus | 5.672725e-6 |
GO:0042108 | positive regulation of cytokine biosynthetic process | 5.708582e-6 |
GO:0001101 | response to acid | 5.747255e-6 |
GO:0050710 | negative regulation of cytokine secretion | 5.751009e-6 |
GO:0071675 | regulation of mononuclear cell migration | 6.770316e-6 |
GO:0060078 | regulation of postsynaptic membrane potential | 7.004552e-6 |
GO:0060996 | dendritic spine development | 7.527009e-6 |
GO:0043066 | negative regulation of apoptosis | 7.627223e-6 |
GO:0019087 | transformation of host cell by virus | 8.467573e-6 |
GO:0035621 | ER to Golgi ceramide transport | 9.872620e-6 |
GO:0048675 | axon extension | 1.012488e-5 |
GO:0046479 | glycosphingolipid catabolic process | 1.016385e-5 |
GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway | 1.023271e-5 |
GO:0060997 | dendritic spine morphogenesis | 1.044126e-5 |
GO:2000106 | regulation of leukocyte apoptosis | 1.104632e-5 |
GO:0090116 | C-5 methylation of cytosine | 1.121024e-5 |
GO:0002688 | regulation of leukocyte chemotaxis | 1.179662e-5 |
GO:0017085 | response to insecticide | 1.180931e-5 |
GO:0006913 | nucleocytoplasmic transport | 1.206770e-5 |
GO:0002444 | myeloid leukocyte mediated immunity | 1.213932e-5 |
GO:0046330 | positive regulation of JNK cascade | 1.260392e-5 |
GO:0071636 | positive regulation of transforming growth factor beta production | 1.380443e-5 |
GO:0042035 | regulation of cytokine biosynthetic process | 1.406794e-5 |
GO:0023035 | CD40 signaling pathway | 1.462829e-5 |
GO:0043069 | negative regulation of programmed cell death | 1.641689e-5 |
GO:0044070 | regulation of anion transport | 1.796370e-5 |
GO:0060548 | negative regulation of cell death | 1.799446e-5 |
GO:0010876 | lipid localization | 2.032801e-5 |
GO:0019377 | glycolipid catabolic process | 2.049868e-5 |
GO:0017038 | protein import | 2.081181e-5 |
GO:0051169 | nuclear transport | 2.366668e-5 |
GO:0001937 | negative regulation of endothelial cell proliferation | 2.379472e-5 |
GO:0000422 | mitochondrion degradation | 2.458572e-5 |
GO:0019915 | lipid storage | 2.566504e-5 |
GO:0051041 | positive regulation of calcium-independent cell-cell adhesion | 2.722405e-5 |
GO:0050902 | leukocyte adhesive activation | 2.722405e-5 |
GO:0015801 | aromatic amino acid transport | 2.732233e-5 |
GO:0002502 | peptide antigen assembly with MHC class I protein complex | 2.759136e-5 |
GO:0051168 | nuclear export | 2.790395e-5 |
GO:0048596 | embryonic camera-type eye morphogenesis | 2.794052e-5 |
GO:0071622 | regulation of granulocyte chemotaxis | 2.966967e-5 |
GO:0010596 | negative regulation of endothelial cell migration | 3.041162e-5 |
GO:0031114 | regulation of microtubule depolymerization | 3.210596e-5 |
GO:0031670 | cellular response to nutrient | 3.305673e-5 |
GO:0002683 | negative regulation of immune system process | 3.405700e-5 |
GO:0006325 | chromatin organization | 3.414760e-5 |
GO:0010754 | negative regulation of cGMP-mediated signaling | 3.579534e-5 |
GO:0043652 | engulfment of apoptotic cell | 3.579534e-5 |
GO:0010751 | negative regulation of nitric oxide mediated signal transduction | 3.579534e-5 |
GO:0002605 | negative regulation of dendritic cell antigen processing and presentation | 3.579534e-5 |
GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 3.579534e-5 |
GO:0061162 | establishment of monopolar cell polarity | 3.760255e-5 |
GO:0071300 | cellular response to retinoic acid | 3.792981e-5 |
GO:0050921 | positive regulation of chemotaxis | 3.943790e-5 |
GO:0002523 | leukocyte migration involved in inflammatory response | 4.066484e-5 |
GO:0002577 | regulation of antigen processing and presentation | 4.146533e-5 |
GO:0060900 | embryonic camera-type eye formation | 4.368347e-5 |
GO:0048048 | embryonic eye morphogenesis | 4.369557e-5 |
GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus | 4.916106e-5 |
GO:0033026 | negative regulation of mast cell apoptosis | 4.934188e-5 |
GO:0021506 | anterior neuropore closure | 5.396143e-5 |
GO:0046325 | negative regulation of glucose import | 5.985514e-5 |
GO:0043170 | macromolecule metabolic process | 6.009902e-5 |
GO:0051893 | regulation of focal adhesion assembly | 6.142508e-5 |
GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport | 6.558086e-5 |
GO:0016568 | chromatin modification | 6.710571e-5 |
GO:0042325 | regulation of phosphorylation | 6.821878e-5 |
GO:0010627 | regulation of intracellular protein kinase cascade | 7.607658e-5 |
GO:0045994 | positive regulation of translational initiation by iron | 8.460701e-5 |
GO:0002037 | negative regulation of L-glutamate transport | 8.460701e-5 |
GO:0032776 | DNA methylation on cytosine | 8.633360e-5 |
GO:0051938 | L-glutamate import | 8.673385e-5 |
GO:0031111 | negative regulation of microtubule polymerization or depolymerization | 8.699322e-5 |
GO:0060021 | palate development | 8.709380e-5 |
GO:0043536 | positive regulation of blood vessel endothelial cell migration | 8.798925e-5 |
GO:0006886 | intracellular protein transport | 8.916683e-5 |
GO:2000276 | negative regulation of oxidative phosphorylation uncoupler activity | 9.448703e-5 |
GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway | 9.448703e-5 |
GO:0009191 | ribonucleoside diphosphate catabolic process | 9.692215e-5 |
GO:0060079 | regulation of excitatory postsynaptic membrane potential | 1.010435e-4 |
GO:0006383 | transcription from RNA polymerase III promoter | 1.030087e-4 |
GO:0006116 | NADH oxidation | 1.036376e-4 |
GO:0007026 | negative regulation of microtubule depolymerization | 1.080331e-4 |
GO:0071283 | cellular response to iron(III) ion | 1.093315e-4 |
GO:0031860 | telomeric 3' overhang formation | 1.093315e-4 |
GO:0060623 | regulation of chromosome condensation | 1.093315e-4 |
GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore | 1.093315e-4 |
GO:0046680 | response to DDT | 1.093315e-4 |
GO:0048535 | lymph node development | 1.101453e-4 |
GO:0032680 | regulation of tumor necrosis factor production | 1.140186e-4 |
GO:0070887 | cellular response to chemical stimulus | 1.163155e-4 |
GO:0043535 | regulation of blood vessel endothelial cell migration | 1.186353e-4 |
GO:0048704 | embryonic skeletal system morphogenesis | 1.205363e-4 |
GO:2000296 | negative regulation of hydrogen peroxide catabolic process | 1.245186e-4 |
GO:0001932 | regulation of protein phosphorylation | 1.270313e-4 |
GO:0043537 | negative regulation of blood vessel endothelial cell migration | 1.288496e-4 |
GO:0015742 | alpha-ketoglutarate transport | 1.306775e-4 |
GO:0051956 | negative regulation of amino acid transport | 1.322366e-4 |
GO:0018149 | peptide cross-linking | 1.360425e-4 |
GO:0042246 | tissue regeneration | 1.378298e-4 |
GO:0014075 | response to amine stimulus | 1.384807e-4 |
GO:0048562 | embryonic organ morphogenesis | 1.394919e-4 |
GO:0071383 | cellular response to steroid hormone stimulus | 1.413944e-4 |
GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis | 1.418472e-4 |
GO:0050863 | regulation of T cell activation | 1.427060e-4 |
GO:0034605 | cellular response to heat | 1.445716e-4 |
GO:0048532 | anatomical structure arrangement | 1.454626e-4 |
GO:0016358 | dendrite development | 1.456791e-4 |
GO:0042742 | defense response to bacterium | 1.481198e-4 |
GO:0043508 | negative regulation of JUN kinase activity | 1.496377e-4 |
GO:0046642 | negative regulation of alpha-beta T cell proliferation | 1.499485e-4 |
GO:0071233 | cellular response to leucine | 1.529676e-4 |
GO:0009590 | detection of gravity | 1.529676e-4 |
GO:0019220 | regulation of phosphate metabolic process | 1.535638e-4 |
GO:0010594 | regulation of endothelial cell migration | 1.541671e-4 |
GO:0070668 | positive regulation of mast cell proliferation | 1.566906e-4 |
GO:0006275 | regulation of DNA replication | 1.598065e-4 |
GO:0016049 | cell growth | 1.647822e-4 |
GO:0050930 | induction of positive chemotaxis | 1.668186e-4 |
GO:0045580 | regulation of T cell differentiation | 1.689733e-4 |
GO:0045773 | positive regulation of axon extension | 1.740475e-4 |
GO:0006611 | protein export from nucleus | 1.746105e-4 |
GO:0072384 | organelle transport along microtubule | 1.749366e-4 |
GO:0002604 | regulation of dendritic cell antigen processing and presentation | 1.884448e-4 |
GO:0009605 | response to external stimulus | 1.906959e-4 |
GO:0051208 | sequestering of calcium ion | 1.999086e-4 |
GO:0070673 | response to interleukin-18 | 2.034779e-4 |
GO:0009615 | response to virus | 2.113593e-4 |
GO:0035249 | synaptic transmission, glutamatergic | 2.158160e-4 |
GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis | 2.254990e-4 |
GO:0001953 | negative regulation of cell-matrix adhesion | 2.265522e-4 |
GO:0002694 | regulation of leukocyte activation | 2.320204e-4 |
GO:0021623 | oculomotor nerve formation | 2.334381e-4 |
GO:0003409 | optic cup structural organization | 2.334381e-4 |
GO:0003404 | optic vesicle morphogenesis | 2.334381e-4 |
GO:0031399 | regulation of protein modification process | 2.400644e-4 |
GO:0030574 | collagen catabolic process | 2.424459e-4 |
GO:0031627 | telomeric loop formation | 2.428872e-4 |
GO:0051323 | metaphase | 2.431223e-4 |
GO:0050920 | regulation of chemotaxis | 2.458596e-4 |
GO:0051549 | positive regulation of keratinocyte migration | 2.551605e-4 |
GO:0051716 | cellular response to stimulus | 2.582608e-4 |
GO:0043030 | regulation of macrophage activation | 2.623316e-4 |
GO:0031668 | cellular response to extracellular stimulus | 2.633948e-4 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 2.646918e-4 |
GO:0043542 | endothelial cell migration | 2.649492e-4 |
GO:0043506 | regulation of JUN kinase activity | 2.657384e-4 |
GO:0010765 | positive regulation of sodium ion transport | 2.751394e-4 |
GO:0001819 | positive regulation of cytokine production | 2.763930e-4 |
GO:0033673 | negative regulation of kinase activity | 2.818245e-4 |
GO:0050789 | regulation of biological process | 2.829936e-4 |
GO:0043534 | blood vessel endothelial cell migration | 2.967993e-4 |
GO:0007132 | meiotic metaphase I | 2.973898e-4 |
GO:0048680 | positive regulation of axon regeneration | 3.128801e-4 |
GO:0047497 | mitochondrion transport along microtubule | 3.144526e-4 |
GO:0044243 | multicellular organismal catabolic process | 3.152741e-4 |
GO:0071230 | cellular response to amino acid stimulus | 3.196960e-4 |
GO:0032890 | regulation of organic acid transport | 3.446732e-4 |
GO:0051249 | regulation of lymphocyte activation | 3.467749e-4 |
GO:0046364 | monosaccharide biosynthetic process | 3.551764e-4 |
GO:0050794 | regulation of cellular process | 3.597537e-4 |
GO:0016998 | cell wall macromolecule catabolic process | 3.665552e-4 |
GO:0043405 | regulation of MAP kinase activity | 3.758901e-4 |
GO:0000165 | MAPKKK cascade | 3.760557e-4 |
GO:0014012 | peripheral nervous system axon regeneration | 3.788286e-4 |
GO:0010243 | response to organic nitrogen | 3.866793e-4 |
GO:0015813 | L-glutamate transport | 3.949645e-4 |
GO:0010763 | positive regulation of fibroblast migration | 3.957293e-4 |
GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 3.965374e-4 |
GO:0043549 | regulation of kinase activity | 3.965903e-4 |
GO:0033504 | floor plate development | 4.035659e-4 |
GO:0015807 | L-amino acid transport | 4.111746e-4 |
GO:0001667 | ameboidal cell migration | 4.161669e-4 |
GO:0021758 | putamen development | 4.287071e-4 |
GO:0021757 | caudate nucleus development | 4.287071e-4 |
GO:0009408 | response to heat | 4.297143e-4 |
GO:0042997 | negative regulation of Golgi to plasma membrane protein transport | 4.327409e-4 |
GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway | 4.343787e-4 |
GO:0010629 | negative regulation of gene expression | 4.432259e-4 |
GO:0043032 | positive regulation of macrophage activation | 4.474739e-4 |
GO:0051649 | establishment of localization in cell | 4.534701e-4 |
GO:0044260 | cellular macromolecule metabolic process | 4.545821e-4 |
GO:0046466 | membrane lipid catabolic process | 4.599718e-4 |
GO:0033025 | regulation of mast cell apoptosis | 4.602256e-4 |
GO:0051301 | cell division | 4.716781e-4 |
GO:0040040 | thermosensory behavior | 4.773388e-4 |
GO:0006094 | gluconeogenesis | 4.797426e-4 |
GO:0010595 | positive regulation of endothelial cell migration | 4.849890e-4 |
GO:0010842 | retina layer formation | 4.882166e-4 |
GO:0043330 | response to exogenous dsRNA | 4.926252e-4 |
GO:0071396 | cellular response to lipid | 4.937175e-4 |
GO:0045619 | regulation of lymphocyte differentiation | 4.950949e-4 |
GO:0044036 | cell wall macromolecule metabolic process | 4.958038e-4 |
GO:0033189 | response to vitamin A | 5.128114e-4 |
GO:0051170 | nuclear import | 5.165162e-4 |
GO:0032494 | response to peptidoglycan | 5.313169e-4 |
GO:0042472 | inner ear morphogenesis | 5.319020e-4 |
GO:0002072 | optic cup morphogenesis involved in camera-type eye development | 5.354055e-4 |
GO:0021603 | cranial nerve formation | 5.476111e-4 |
GO:0051234 | establishment of localization | 5.540963e-4 |
GO:0045627 | positive regulation of T-helper 1 cell differentiation | 5.598896e-4 |
GO:0060363 | cranial suture morphogenesis | 5.639957e-4 |
GO:0051338 | regulation of transferase activity | 5.785432e-4 |
GO:0043408 | regulation of MAPKKK cascade | 5.806776e-4 |
GO:0006048 | UDP-N-acetylglucosamine biosynthetic process | 5.843271e-4 |
GO:0002696 | positive regulation of leukocyte activation | 5.844240e-4 |
GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway | 5.852340e-4 |
GO:0060004 | reflex | 5.904691e-4 |
GO:0006447 | regulation of translational initiation by iron | 5.941140e-4 |
GO:0033036 | macromolecule localization | 5.948578e-4 |
GO:0071224 | cellular response to peptidoglycan | 5.949314e-4 |
GO:0042221 | response to chemical stimulus | 5.979253e-4 |
GO:0048333 | mesodermal cell differentiation | 6.000261e-4 |
GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 6.033454e-4 |
GO:0015696 | ammonium transport | 6.099337e-4 |
GO:0071404 | cellular response to low-density lipoprotein particle stimulus | 6.099337e-4 |
GO:0006991 | response to sterol depletion | 6.101357e-4 |
GO:0048520 | positive regulation of behavior | 6.140929e-4 |
GO:0000244 | assembly of spliceosomal tri-snRNP | 6.150142e-4 |
GO:0046349 | amino sugar biosynthetic process | 6.356841e-4 |
GO:0051276 | chromosome organization | 6.483762e-4 |
GO:0006954 | inflammatory response | 6.493323e-4 |
GO:0031076 | embryonic camera-type eye development | 6.738971e-4 |
GO:0071470 | cellular response to osmotic stress | 6.780019e-4 |
GO:0006695 | cholesterol biosynthetic process | 6.793216e-4 |
GO:0043901 | negative regulation of multi-organism process | 6.877885e-4 |
GO:0051348 | negative regulation of transferase activity | 6.943172e-4 |
GO:0051295 | establishment of meiotic spindle localization | 6.971006e-4 |
GO:0007019 | microtubule depolymerization | 7.112444e-4 |
GO:0016126 | sterol biosynthetic process | 7.208112e-4 |
GO:0006469 | negative regulation of protein kinase activity | 7.307718e-4 |
GO:0071402 | cellular response to lipoprotein particle stimulus | 7.392191e-4 |
GO:0050865 | regulation of cell activation | 7.397758e-4 |
GO:0030501 | positive regulation of bone mineralization | 7.409190e-4 |
GO:0031440 | regulation of mRNA 3'-end processing | 7.474292e-4 |
GO:0030278 | regulation of ossification | 7.545003e-4 |
GO:0002376 | immune system process | 7.627034e-4 |
GO:0071474 | cellular hyperosmotic response | 7.908002e-4 |
GO:2000377 | regulation of reactive oxygen species metabolic process | 8.085396e-4 |
GO:0006338 | chromatin remodeling | 8.149729e-4 |
GO:0006606 | protein import into nucleus | 8.154667e-4 |
GO:0050892 | intestinal absorption | 8.342459e-4 |
GO:0035695 | mitochondrion degradation by induced vacuole formation | 8.349763e-4 |
GO:0014739 | positive regulation of muscle hyperplasia | 8.349763e-4 |
GO:0030149 | sphingolipid catabolic process | 8.375465e-4 |
GO:0009790 | embryo development | 8.397498e-4 |
GO:0015031 | protein transport | 8.412446e-4 |
GO:0006810 | transport | 8.575305e-4 |
GO:2000108 | positive regulation of leukocyte apoptosis | 8.791507e-4 |
GO:0045778 | positive regulation of ossification | 8.841101e-4 |
GO:0002532 | production of molecular mediator involved in inflammatory response | 8.849802e-4 |
GO:0033143 | regulation of steroid hormone receptor signaling pathway | 8.857633e-4 |
GO:0002819 | regulation of adaptive immune response | 8.957839e-4 |
GO:0015800 | acidic amino acid transport | 8.995454e-4 |
GO:0070071 | proton-transporting two-sector ATPase complex assembly | 9.154670e-4 |
GO:0007501 | mesodermal cell fate specification | 9.315022e-4 |
GO:0065007 | biological regulation | 9.456023e-4 |
GO:0001775 | cell activation | 9.517533e-4 |
GO:0048588 | developmental cell growth | 9.591253e-4 |
GO:0000375 | RNA splicing, via transesterification reactions | 9.647137e-4 |
GO:0071418 | cellular response to amine stimulus | 9.759872e-4 |
GO:0014020 | primary neural tube formation | 1.007654e-3 |
GO:0016569 | covalent chromatin modification | 1.008546e-3 |
GO:0001710 | mesodermal cell fate commitment | 1.008753e-3 |
GO:0006935 | chemotaxis | 1.013943e-3 |
GO:0050870 | positive regulation of T cell activation | 1.023527e-3 |
GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway | 1.026734e-3 |
GO:0007018 | microtubule-based movement | 1.060855e-3 |
GO:0033145 | positive regulation of steroid hormone receptor signaling pathway | 1.070256e-3 |
GO:0000910 | cytokinesis | 1.080546e-3 |
GO:0045859 | regulation of protein kinase activity | 1.135874e-3 |
GO:0016925 | protein sumoylation | 1.165222e-3 |
GO:2000275 | regulation of oxidative phosphorylation uncoupler activity | 1.167541e-3 |
GO:0071712 | ER-associated misfolded protein catabolic process | 1.171319e-3 |
GO:0002536 | respiratory burst involved in inflammatory response | 1.183101e-3 |
GO:0006734 | NADH metabolic process | 1.205239e-3 |
GO:0007389 | pattern specification process | 1.205538e-3 |
GO:0030299 | intestinal cholesterol absorption | 1.206323e-3 |
GO:0044238 | primary metabolic process | 1.213740e-3 |
GO:0043243 | positive regulation of protein complex disassembly | 1.222693e-3 |
GO:0042471 | ear morphogenesis | 1.235477e-3 |
GO:0061028 | establishment of endothelial barrier | 1.235992e-3 |
GO:0002315 | marginal zone B cell differentiation | 1.266263e-3 |
GO:0045064 | T-helper 2 cell differentiation | 1.266263e-3 |
GO:0001841 | neural tube formation | 1.275686e-3 |
GO:0006952 | defense response | 1.296925e-3 |
GO:0009181 | purine ribonucleoside diphosphate catabolic process | 1.305209e-3 |
GO:0060264 | regulation of respiratory burst involved in inflammatory response | 1.308780e-3 |
GO:0071417 | cellular response to organic nitrogen | 1.319959e-3 |
GO:0070169 | positive regulation of biomineral tissue development | 1.329868e-3 |
GO:0001944 | vasculature development | 1.330261e-3 |
GO:0010966 | regulation of phosphate transport | 1.342277e-3 |
GO:0032502 | developmental process | 1.369938e-3 |
GO:0016042 | lipid catabolic process | 1.378995e-3 |
GO:0034637 | cellular carbohydrate biosynthetic process | 1.386717e-3 |
GO:0050709 | negative regulation of protein secretion | 1.391202e-3 |
GO:0002011 | morphogenesis of an epithelial sheet | 1.392569e-3 |
GO:0001843 | neural tube closure | 1.412740e-3 |
GO:0055067 | monovalent inorganic cation homeostasis | 1.417621e-3 |
GO:0002822 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.438894e-3 |
GO:0045740 | positive regulation of DNA replication | 1.467297e-3 |
GO:0002520 | immune system development | 1.469150e-3 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 1.487183e-3 |
GO:0009987 | cellular process | 1.521297e-3 |
GO:0002036 | regulation of L-glutamate transport | 1.552476e-3 |
GO:0016576 | histone dephosphorylation | 1.552476e-3 |
GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning | 1.556834e-3 |
GO:0040038 | polar body extrusion after meiotic divisions | 1.581222e-3 |
GO:0034504 | protein localization to nucleus | 1.596478e-3 |
GO:0045132 | meiotic chromosome segregation | 1.613220e-3 |
GO:0043406 | positive regulation of MAP kinase activity | 1.621606e-3 |
GO:0006664 | glycolipid metabolic process | 1.627834e-3 |
GO:0006351 | transcription, DNA-dependent | 1.637995e-3 |
GO:0051953 | negative regulation of amine transport | 1.656224e-3 |
GO:0051043 | regulation of membrane protein ectodomain proteolysis | 1.664168e-3 |
GO:0050867 | positive regulation of cell activation | 1.676208e-3 |
GO:0046640 | regulation of alpha-beta T cell proliferation | 1.682821e-3 |
GO:0002544 | chronic inflammatory response | 1.682991e-3 |
GO:0046324 | regulation of glucose import | 1.684711e-3 |
GO:0048534 | hemopoietic or lymphoid organ development | 1.710623e-3 |
GO:0006694 | steroid biosynthetic process | 1.720386e-3 |
GO:0009892 | negative regulation of metabolic process | 1.775465e-3 |
GO:0048280 | vesicle fusion with Golgi apparatus | 1.788143e-3 |
GO:0010996 | response to auditory stimulus | 1.788143e-3 |
GO:0030500 | regulation of bone mineralization | 1.788844e-3 |
GO:0048496 | maintenance of organ identity | 1.798122e-3 |
GO:0090072 | positive regulation of sodium ion transport via voltage-gated sodium channel activity | 1.798122e-3 |
GO:0045663 | positive regulation of myoblast differentiation | 1.806636e-3 |
GO:0051097 | negative regulation of helicase activity | 1.812331e-3 |
GO:0045082 | positive regulation of interleukin-10 biosynthetic process | 1.814621e-3 |
GO:0021602 | cranial nerve morphogenesis | 1.829037e-3 |
GO:0000398 | nuclear mRNA splicing, via spliceosome | 1.911843e-3 |
GO:0051247 | positive regulation of protein metabolic process | 1.930786e-3 |
GO:0019428 | allantoin biosynthetic process | 1.934095e-3 |
GO:0050830 | defense response to Gram-positive bacterium | 1.937121e-3 |
GO:0007166 | cell surface receptor linked signaling pathway | 1.939109e-3 |
GO:0030097 | hemopoiesis | 1.941291e-3 |
GO:0006073 | cellular glucan metabolic process | 1.990761e-3 |
GO:0060606 | tube closure | 1.999961e-3 |
GO:0043092 | L-amino acid import | 2.033357e-3 |
GO:0035767 | endothelial cell chemotaxis | 2.058162e-3 |
GO:0043090 | amino acid import | 2.101113e-3 |
GO:0045765 | regulation of angiogenesis | 2.206011e-3 |
GO:0043903 | regulation of symbiosis, encompassing mutualism through parasitism | 2.214790e-3 |
GO:2000378 | negative regulation of reactive oxygen species metabolic process | 2.233227e-3 |
GO:0010829 | negative regulation of glucose transport | 2.233227e-3 |
GO:0008625 | induction of apoptosis via death domain receptors | 2.233227e-3 |
GO:0030099 | myeloid cell differentiation | 2.278502e-3 |
GO:0021545 | cranial nerve development | 2.287670e-3 |
GO:0016570 | histone modification | 2.343544e-3 |
GO:0070228 | regulation of lymphocyte apoptosis | 2.362747e-3 |
GO:0009301 | snRNA transcription | 2.373805e-3 |
GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase | 2.413420e-3 |
GO:0016198 | axon choice point recognition | 2.424304e-3 |
GO:0032743 | positive regulation of interleukin-2 production | 2.426180e-3 |
GO:2001014 | regulation of skeletal muscle cell differentiation | 2.454486e-3 |
GO:0070588 | calcium ion transmembrane transport | 2.454702e-3 |
GO:0033033 | negative regulation of myeloid cell apoptosis | 2.461962e-3 |
GO:0070170 | regulation of tooth mineralization | 2.465608e-3 |
GO:0008380 | RNA splicing | 2.473362e-3 |
GO:0030279 | negative regulation of ossification | 2.476540e-3 |
GO:0051917 | regulation of fibrinolysis | 2.486827e-3 |
GO:0007270 | neuron-neuron synaptic transmission | 2.493002e-3 |
GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis | 2.526654e-3 |
GO:0071900 | regulation of protein serine/threonine kinase activity | 2.541296e-3 |
GO:0009611 | response to wounding | 2.561429e-3 |
GO:0051897 | positive regulation of protein kinase B signaling cascade | 2.598096e-3 |
GO:0050918 | positive chemotaxis | 2.631385e-3 |
GO:0032608 | interferon-beta production | 2.672919e-3 |
GO:0032872 | regulation of stress-activated MAPK cascade | 2.679141e-3 |
GO:0007289 | spermatid nucleus differentiation | 2.688670e-3 |
GO:0030516 | regulation of axon extension | 2.708677e-3 |
GO:0031295 | T cell costimulation | 2.727827e-3 |
GO:0044130 | negative regulation of growth of symbiont in host | 2.728385e-3 |
GO:0051654 | establishment of mitochondrion localization | 2.757028e-3 |
GO:0032268 | regulation of cellular protein metabolic process | 2.819421e-3 |
GO:0001756 | somitogenesis | 2.859492e-3 |
GO:0046684 | response to pyrethroid | 2.883272e-3 |
GO:0006931 | substrate-dependent cell migration, cell attachment to substrate | 2.883272e-3 |
GO:0006911 | phagocytosis, engulfment | 2.886382e-3 |
GO:0018199 | peptidyl-glutamine modification | 2.892258e-3 |
GO:0007165 | signal transduction | 2.927442e-3 |
GO:2000191 | regulation of fatty acid transport | 2.932759e-3 |
GO:0034694 | response to prostaglandin stimulus | 2.952493e-3 |
GO:0003334 | keratinocyte development | 2.980037e-3 |
GO:0006417 | regulation of translation | 2.990936e-3 |
GO:0045123 | cellular extravasation | 2.997031e-3 |
GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator | 3.000520e-3 |
GO:0010812 | negative regulation of cell-substrate adhesion | 3.010139e-3 |
GO:0006607 | NLS-bearing substrate import into nucleus | 3.015523e-3 |
GO:0006817 | phosphate ion transport | 3.036134e-3 |
GO:0031112 | positive regulation of microtubule polymerization or depolymerization | 3.061754e-3 |
GO:0009088 | threonine biosynthetic process | 3.078638e-3 |
GO:0032606 | type I interferon production | 3.080377e-3 |
GO:0071634 | regulation of transforming growth factor beta production | 3.117988e-3 |
GO:0044314 | protein K27-linked ubiquitination | 3.134260e-3 |
GO:0035567 | non-canonical Wnt receptor signaling pathway | 3.151687e-3 |
GO:0045084 | positive regulation of interleukin-12 biosynthetic process | 3.155189e-3 |
GO:0042060 | wound healing | 3.177364e-3 |
GO:0033365 | protein localization to organelle | 3.193190e-3 |
GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway | 3.195215e-3 |
GO:0005977 | glycogen metabolic process | 3.217924e-3 |
GO:0015858 | nucleoside transport | 3.223584e-3 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 3.232704e-3 |
GO:0070167 | regulation of biomineral tissue development | 3.234457e-3 |
GO:0032148 | activation of protein kinase B activity | 3.255778e-3 |
GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process | 3.278707e-3 |
GO:0019730 | antimicrobial humoral response | 3.333184e-3 |
GO:0007042 | lysosomal lumen acidification | 3.333184e-3 |
GO:0051250 | negative regulation of lymphocyte activation | 3.348379e-3 |
GO:0045625 | regulation of T-helper 1 cell differentiation | 3.440820e-3 |
GO:0006687 | glycosphingolipid metabolic process | 3.458333e-3 |
GO:0032873 | negative regulation of stress-activated MAPK cascade | 3.463366e-3 |
GO:0090100 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 3.483907e-3 |
GO:0009967 | positive regulation of signal transduction | 3.504955e-3 |
GO:0045184 | establishment of protein localization | 3.513852e-3 |
GO:0006811 | ion transport | 3.516226e-3 |
GO:0002709 | regulation of T cell mediated immunity | 3.532413e-3 |
GO:0001707 | mesoderm formation | 3.578834e-3 |
GO:2001021 | negative regulation of response to DNA damage stimulus | 3.580737e-3 |
GO:0071379 | cellular response to prostaglandin stimulus | 3.583446e-3 |
GO:0035418 | protein localization to synapse | 3.583446e-3 |
GO:0031110 | regulation of microtubule polymerization or depolymerization | 3.599494e-3 |
GO:0035419 | activation of MAPK activity involved in innate immune response | 3.604153e-3 |
GO:0070172 | positive regulation of tooth mineralization | 3.626999e-3 |
GO:2000463 | positive regulation of excitatory postsynaptic membrane potential | 3.665983e-3 |
GO:0007231 | osmosensory signaling pathway | 3.739853e-3 |
GO:0007420 | brain development | 3.802752e-3 |
GO:0048178 | negative regulation of hepatocyte growth factor biosynthetic process | 3.815311e-3 |
GO:0060390 | regulation of SMAD protein import into nucleus | 3.825796e-3 |
GO:0043401 | steroid hormone mediated signaling pathway | 3.866754e-3 |
GO:0060754 | positive regulation of mast cell chemotaxis | 3.872616e-3 |
GO:0014738 | regulation of muscle hyperplasia | 3.883847e-3 |
GO:0030573 | bile acid catabolic process | 3.892409e-3 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 4.001728e-3 |
GO:0009059 | macromolecule biosynthetic process | 4.004354e-3 |
GO:0048856 | anatomical structure development | 4.022432e-3 |
GO:0001768 | establishment of T cell polarity | 4.027468e-3 |
GO:0048706 | embryonic skeletal system development | 4.059764e-3 |
GO:0007199 | G-protein signaling, coupled to cGMP nucleotide second messenger | 4.081297e-3 |
GO:0002030 | inhibitory G-protein coupled receptor phosphorylation | 4.086396e-3 |
GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning | 4.102640e-3 |
GO:0033205 | cell cycle cytokinesis | 4.133362e-3 |
GO:0051240 | positive regulation of multicellular organismal process | 4.150133e-3 |
GO:0045621 | positive regulation of lymphocyte differentiation | 4.228195e-3 |
GO:0050729 | positive regulation of inflammatory response | 4.267287e-3 |
GO:0060266 | negative regulation of respiratory burst involved in inflammatory response | 4.271672e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:2000253 | positive regulation of feeding behavior | 2.049210e-8 |
GO:2000507 | positive regulation of energy homeostasis | 2.049210e-8 |
GO:0072539 | T-helper 17 cell differentiation | 3.372211e-8 |
GO:0043407 | negative regulation of MAP kinase activity | 3.878247e-8 |
GO:0071168 | protein localization to chromatin | 1.131136e-7 |
GO:2000505 | regulation of energy homeostasis | 1.535312e-7 |
GO:0014816 | satellite cell differentiation | 2.938598e-7 |
GO:0071169 | establishment of protein localization to chromatin | 3.435793e-7 |
GO:0034435 | cholesterol esterification | 6.554814e-7 |
GO:0071901 | negative regulation of protein serine/threonine kinase activity | 1.152920e-6 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 1.305434e-6 |
GO:0046356 | acetyl-CoA catabolic process | 1.940216e-6 |
GO:0060041 | retina development in camera-type eye | 2.355084e-6 |
GO:0007128 | meiotic prophase I | 2.578509e-6 |
GO:0009109 | coenzyme catabolic process | 3.496151e-6 |
GO:0051187 | cofactor catabolic process | 3.813542e-6 |
GO:0071822 | protein complex subunit organization | 6.972345e-6 |
GO:0090049 | regulation of cell migration involved in sprouting angiogenesis | 1.180492e-5 |
GO:0007127 | meiosis I | 1.183137e-5 |
GO:0045807 | positive regulation of endocytosis | 1.248689e-5 |
GO:0006084 | acetyl-CoA metabolic process | 1.552175e-5 |
GO:0060259 | regulation of feeding behavior | 1.861888e-5 |
GO:0006099 | tricarboxylic acid cycle | 1.930612e-5 |
GO:0032025 | response to cobalt ion | 2.045183e-5 |
GO:0010738 | regulation of protein kinase A signaling cascade | 2.046477e-5 |
GO:0016579 | protein deubiquitination | 2.060333e-5 |
GO:0032365 | intracellular lipid transport | 2.114217e-5 |
GO:0022027 | interkinetic nuclear migration | 2.296990e-5 |
GO:0070192 | chromosome organization involved in meiosis | 2.335043e-5 |
GO:0017126 | nucleologenesis | 2.415542e-5 |
GO:0030517 | negative regulation of axon extension | 2.634649e-5 |
GO:0030258 | lipid modification | 3.056914e-5 |
GO:0007129 | synapsis | 3.059873e-5 |
GO:0048241 | epinephrine transport | 3.293769e-5 |
GO:0006461 | protein complex assembly | 3.438902e-5 |
GO:0034097 | response to cytokine stimulus | 3.671983e-5 |
GO:0048522 | positive regulation of cellular process | 3.986071e-5 |
GO:0060059 | embryonic retina morphogenesis in camera-type eye | 4.198381e-5 |
GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity | 4.206878e-5 |
GO:0006805 | xenobiotic metabolic process | 4.254355e-5 |
GO:0070271 | protein complex biogenesis | 4.480012e-5 |
GO:0072592 | oxygen metabolic process | 4.809886e-5 |
GO:0015721 | bile acid and bile salt transport | 5.330140e-5 |
GO:0009744 | response to sucrose stimulus | 5.330140e-5 |
GO:0048518 | positive regulation of biological process | 5.409794e-5 |
GO:0034502 | protein localization to chromosome | 5.520048e-5 |
GO:0009069 | serine family amino acid metabolic process | 5.775021e-5 |
GO:0046709 | IDP catabolic process | 6.000963e-5 |
GO:0046032 | ADP catabolic process | 6.000963e-5 |
GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway | 6.347879e-5 |
GO:0019428 | allantoin biosynthetic process | 6.503500e-5 |
GO:0000279 | M phase | 6.685726e-5 |
GO:0070193 | synaptonemal complex organization | 6.939122e-5 |
GO:0045333 | cellular respiration | 7.013572e-5 |
GO:0010594 | regulation of endothelial cell migration | 7.031947e-5 |
GO:0021512 | spinal cord anterior/posterior patterning | 7.305832e-5 |
GO:0042130 | negative regulation of T cell proliferation | 8.688416e-5 |
GO:0071398 | cellular response to fatty acid | 8.811258e-5 |
GO:0010739 | positive regulation of protein kinase A signaling cascade | 9.063128e-5 |
GO:0006547 | histidine metabolic process | 9.182290e-5 |
GO:0000188 | inactivation of MAPK activity | 9.411375e-5 |
GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity | 9.568794e-5 |
GO:0001525 | angiogenesis | 9.901532e-5 |
GO:0006833 | water transport | 9.940471e-5 |
GO:0046642 | negative regulation of alpha-beta T cell proliferation | 1.008841e-4 |
GO:0006102 | isocitrate metabolic process | 1.067474e-4 |
GO:0006734 | NADH metabolic process | 1.134251e-4 |
GO:0006488 | dolichol-linked oligosaccharide biosynthetic process | 1.207994e-4 |
GO:0032792 | negative regulation of CREB transcription factor activity | 1.235848e-4 |
GO:0032065 | cortical protein anchoring | 1.305278e-4 |
GO:0000027 | ribosomal large subunit assembly | 1.305278e-4 |
GO:0000105 | histidine biosynthetic process | 1.460365e-4 |
GO:0009191 | ribonucleoside diphosphate catabolic process | 1.506965e-4 |
GO:0070367 | negative regulation of hepatocyte differentiation | 1.515193e-4 |
GO:0022417 | protein maturation by protein folding | 1.571829e-4 |
GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity | 1.571829e-4 |
GO:0042044 | fluid transport | 1.603267e-4 |
GO:0043409 | negative regulation of MAPKKK cascade | 1.647863e-4 |
GO:0043623 | cellular protein complex assembly | 1.661848e-4 |
GO:0030225 | macrophage differentiation | 1.833694e-4 |
GO:0009410 | response to xenobiotic stimulus | 1.880274e-4 |
GO:0032367 | intracellular cholesterol transport | 1.892274e-4 |
GO:0002021 | response to dietary excess | 1.938511e-4 |
GO:0080164 | regulation of nitric oxide metabolic process | 2.025195e-4 |
GO:0007062 | sister chromatid cohesion | 2.093675e-4 |
GO:0006544 | glycine metabolic process | 2.331194e-4 |
GO:0045665 | negative regulation of neuron differentiation | 2.371024e-4 |
GO:0033762 | response to glucagon stimulus | 2.401509e-4 |
GO:0019674 | NAD metabolic process | 2.445837e-4 |
GO:0030953 | astral microtubule organization | 2.462242e-4 |
GO:0022403 | cell cycle phase | 2.483950e-4 |
GO:0060291 | long-term synaptic potentiation | 2.688571e-4 |
GO:0070542 | response to fatty acid | 2.831798e-4 |
GO:0043933 | macromolecular complex subunit organization | 2.928488e-4 |
GO:0000238 | zygotene | 3.053671e-4 |
GO:0001944 | vasculature development | 3.160627e-4 |
GO:0009134 | nucleoside diphosphate catabolic process | 3.189713e-4 |
GO:0022900 | electron transport chain | 3.275230e-4 |
GO:0018343 | protein farnesylation | 3.657557e-4 |
GO:0033034 | positive regulation of myeloid cell apoptosis | 3.715136e-4 |
GO:0071285 | cellular response to lithium ion | 3.910760e-4 |
GO:0021764 | amygdala development | 3.936772e-4 |
GO:0015791 | polyol transport | 4.012293e-4 |
GO:0070646 | protein modification by small protein removal | 4.078725e-4 |
GO:0045787 | positive regulation of cell cycle | 4.184577e-4 |
GO:0007130 | synaptonemal complex assembly | 4.268422e-4 |
GO:0045591 | positive regulation of regulatory T cell differentiation | 4.291899e-4 |
GO:0071383 | cellular response to steroid hormone stimulus | 4.369415e-4 |
GO:0006983 | ER overload response | 4.645160e-4 |
GO:0006548 | histidine catabolic process | 4.789860e-4 |
GO:0046499 | S-adenosylmethioninamine metabolic process | 4.852805e-4 |
GO:0070498 | interleukin-1-mediated signaling pathway | 5.004087e-4 |
GO:0030836 | positive regulation of actin filament depolymerization | 5.161235e-4 |
GO:0009185 | ribonucleoside diphosphate metabolic process | 5.360734e-4 |
GO:0051258 | protein polymerization | 5.429108e-4 |
GO:0006507 | GPI anchor release | 5.477468e-4 |
GO:2000178 | negative regulation of neural precursor cell proliferation | 5.506738e-4 |
GO:0006620 | posttranslational protein targeting to membrane | 5.564503e-4 |
GO:0009299 | mRNA transcription | 5.623244e-4 |
GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide | 5.623244e-4 |
GO:0071310 | cellular response to organic substance | 5.677460e-4 |
GO:0060627 | regulation of vesicle-mediated transport | 5.725731e-4 |
GO:0006584 | catecholamine metabolic process | 5.941487e-4 |
GO:0007220 | Notch receptor processing | 5.986631e-4 |
GO:0051592 | response to calcium ion | 6.109662e-4 |
GO:0006108 | malate metabolic process | 6.120445e-4 |
GO:0045132 | meiotic chromosome segregation | 6.175301e-4 |
GO:0051900 | regulation of mitochondrial depolarization | 6.333132e-4 |
GO:0044092 | negative regulation of molecular function | 6.400997e-4 |
GO:0002268 | follicular dendritic cell differentiation | 6.738322e-4 |
GO:0048514 | blood vessel morphogenesis | 6.874863e-4 |
GO:0060042 | retina morphogenesis in camera-type eye | 6.921725e-4 |
GO:0009755 | hormone-mediated signaling pathway | 7.052646e-4 |
GO:0034339 | regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor | 7.246029e-4 |
GO:0010038 | response to metal ion | 7.427786e-4 |
GO:0071345 | cellular response to cytokine stimulus | 7.761714e-4 |
GO:0006469 | negative regulation of protein kinase activity | 7.805676e-4 |
GO:0061180 | mammary gland epithelium development | 7.808837e-4 |
GO:0031589 | cell-substrate adhesion | 7.926431e-4 |
GO:0044027 | hypermethylation of CpG island | 8.224843e-4 |
GO:0046618 | drug export | 8.264134e-4 |
GO:0048193 | Golgi vesicle transport | 8.372726e-4 |
GO:0002687 | positive regulation of leukocyte migration | 8.653140e-4 |
GO:0051186 | cofactor metabolic process | 8.655024e-4 |
GO:0034440 | lipid oxidation | 8.704676e-4 |
GO:0007131 | reciprocal meiotic recombination | 9.086914e-4 |
GO:0043950 | positive regulation of cAMP-mediated signaling | 9.121499e-4 |
GO:0032608 | interferon-beta production | 9.121499e-4 |
GO:0070165 | positive regulation of adiponectin secretion | 9.159759e-4 |
GO:0033031 | positive regulation of neutrophil apoptosis | 9.159759e-4 |
GO:0060409 | positive regulation of acetylcholine metabolic process | 9.213257e-4 |
GO:0006829 | zinc ion transport | 9.536232e-4 |
GO:0060644 | mammary gland epithelial cell differentiation | 1.004088e-3 |
GO:0051716 | cellular response to stimulus | 1.028633e-3 |
GO:0010948 | negative regulation of cell cycle process | 1.029301e-3 |
GO:0048242 | epinephrine secretion | 1.076782e-3 |
GO:0070366 | regulation of hepatocyte differentiation | 1.082416e-3 |
GO:0042415 | norepinephrine metabolic process | 1.086618e-3 |
GO:0007166 | cell surface receptor linked signaling pathway | 1.089835e-3 |
GO:0033240 | positive regulation of cellular amine metabolic process | 1.154657e-3 |
GO:0051901 | positive regulation of mitochondrial depolarization | 1.167564e-3 |
GO:0045143 | homologous chromosome segregation | 1.167564e-3 |
GO:0007229 | integrin-mediated signaling pathway | 1.187645e-3 |
GO:0001568 | blood vessel development | 1.198336e-3 |
GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan | 1.207210e-3 |
GO:0048260 | positive regulation of receptor-mediated endocytosis | 1.208232e-3 |
GO:0065003 | macromolecular complex assembly | 1.255424e-3 |
GO:0051546 | keratinocyte migration | 1.260671e-3 |
GO:0006564 | L-serine biosynthetic process | 1.260671e-3 |
GO:0043401 | steroid hormone mediated signaling pathway | 1.281384e-3 |
GO:0033687 | osteoblast proliferation | 1.290623e-3 |
GO:0046031 | ADP metabolic process | 1.290623e-3 |
GO:0003180 | aortic valve morphogenesis | 1.304422e-3 |
GO:0048103 | somatic stem cell division | 1.307165e-3 |
GO:0033673 | negative regulation of kinase activity | 1.357299e-3 |
GO:0048692 | negative regulation of axon extension involved in regeneration | 1.399657e-3 |
GO:2000016 | negative regulation of determination of dorsal identity | 1.399657e-3 |
GO:0006710 | androgen catabolic process | 1.399657e-3 |
GO:0060749 | mammary gland alveolus development | 1.416001e-3 |
GO:0032914 | positive regulation of transforming growth factor beta1 production | 1.429117e-3 |
GO:0048640 | negative regulation of developmental growth | 1.436854e-3 |
GO:0032594 | protein transport within lipid bilayer | 1.441934e-3 |
GO:0030967 | ER-nuclear sterol response pathway | 1.441934e-3 |
GO:0022402 | cell cycle process | 1.484047e-3 |
GO:0017145 | stem cell division | 1.497829e-3 |
GO:0043604 | amide biosynthetic process | 1.594099e-3 |
GO:0070887 | cellular response to chemical stimulus | 1.629809e-3 |
GO:0030100 | regulation of endocytosis | 1.641214e-3 |
GO:0072109 | glomerular mesangium development | 1.650649e-3 |
GO:0010033 | response to organic substance | 1.655608e-3 |
GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis | 1.663883e-3 |
GO:2000386 | positive regulation of ovarian follicle development | 1.697820e-3 |
GO:2000388 | positive regulation of antral ovarian follicle growth | 1.697820e-3 |
GO:2000368 | positive regulation of acrosomal vesicle exocytosis | 1.697820e-3 |
GO:0070370 | cellular heat acclimation | 1.697820e-3 |
GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process | 1.697820e-3 |
GO:0042666 | negative regulation of ectodermal cell fate specification | 1.697820e-3 |
GO:0001809 | positive regulation of type IV hypersensitivity | 1.697820e-3 |
GO:0034621 | cellular macromolecular complex subunit organization | 1.774803e-3 |
GO:0002088 | lens development in camera-type eye | 1.793425e-3 |
GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation | 1.810448e-3 |
GO:0006984 | ER-nucleus signaling pathway | 1.811008e-3 |
GO:0009070 | serine family amino acid biosynthetic process | 1.832852e-3 |
GO:0010866 | regulation of triglyceride biosynthetic process | 1.841998e-3 |
GO:0046013 | regulation of T cell homeostatic proliferation | 1.861709e-3 |
GO:0002444 | myeloid leukocyte mediated immunity | 1.869074e-3 |
GO:0051348 | negative regulation of transferase activity | 1.869904e-3 |
GO:0045598 | regulation of fat cell differentiation | 1.879417e-3 |
GO:0010811 | positive regulation of cell-substrate adhesion | 1.961712e-3 |
GO:0034224 | cellular response to zinc ion starvation | 1.971503e-3 |
GO:0048822 | enucleate erythrocyte development | 2.006555e-3 |
GO:0045726 | positive regulation of integrin biosynthetic process | 2.006555e-3 |
GO:0016042 | lipid catabolic process | 2.052904e-3 |
GO:0070293 | renal absorption | 2.055453e-3 |
GO:0045859 | regulation of protein kinase activity | 2.132174e-3 |
GO:0010193 | response to ozone | 2.196781e-3 |
GO:0007165 | signal transduction | 2.233777e-3 |
GO:0040007 | growth | 2.241266e-3 |
GO:0035562 | negative regulation of chromatin binding | 2.242465e-3 |
GO:0006994 | positive regulation of transcription via sterol regulatory element binding involved in ER-nuclear sterol response pathway | 2.242465e-3 |
GO:0017144 | drug metabolic process | 2.279517e-3 |
GO:0061311 | cell surface receptor linked signaling pathway involved in heart development | 2.333612e-3 |
GO:0045626 | negative regulation of T-helper 1 cell differentiation | 2.337619e-3 |
GO:0016180 | snRNA processing | 2.363702e-3 |
GO:0048537 | mucosal-associated lymphoid tissue development | 2.415830e-3 |
GO:0009583 | detection of light stimulus | 2.422657e-3 |
GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching | 2.423819e-3 |
GO:0043128 | positive regulation of 1-phosphatidylinositol 4-kinase activity | 2.486872e-3 |
GO:0014005 | microglia development | 2.486872e-3 |
GO:0009956 | radial pattern formation | 2.495217e-3 |
GO:0007140 | male meiosis | 2.566076e-3 |
GO:0051050 | positive regulation of transport | 2.632276e-3 |
GO:0010741 | negative regulation of intracellular protein kinase cascade | 2.696873e-3 |
GO:0006290 | pyrimidine dimer repair | 2.709535e-3 |
GO:0016322 | neuron remodeling | 2.738788e-3 |
GO:0071396 | cellular response to lipid | 2.749938e-3 |
GO:0045822 | negative regulation of heart contraction | 2.808990e-3 |
GO:0002690 | positive regulation of leukocyte chemotaxis | 2.951838e-3 |
GO:0010873 | positive regulation of cholesterol esterification | 3.007292e-3 |
GO:0045760 | positive regulation of action potential | 3.024087e-3 |
GO:0048489 | synaptic vesicle transport | 3.115803e-3 |
GO:0010243 | response to organic nitrogen | 3.259845e-3 |
GO:0006949 | syncytium formation | 3.269297e-3 |
GO:0007602 | phototransduction | 3.281954e-3 |
GO:0070543 | response to linoleic acid | 3.294303e-3 |
GO:0045875 | negative regulation of sister chromatid cohesion | 3.294303e-3 |
GO:0034014 | response to triglyceride | 3.294303e-3 |
GO:0034696 | response to prostaglandin F stimulus | 3.294303e-3 |
GO:0003097 | renal water transport | 3.315986e-3 |
GO:0051130 | positive regulation of cellular component organization | 3.476110e-3 |
GO:0071248 | cellular response to metal ion | 3.522665e-3 |
GO:0043535 | regulation of blood vessel endothelial cell migration | 3.538754e-3 |
GO:0019221 | cytokine-mediated signaling pathway | 3.571427e-3 |
GO:0014821 | phasic smooth muscle contraction | 3.611082e-3 |
GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process | 3.613259e-3 |
GO:0070194 | synaptonemal complex disassembly | 3.619433e-3 |
GO:0051775 | response to redox state | 3.619433e-3 |
GO:0048015 | phosphatidylinositol-mediated signaling | 3.635568e-3 |
GO:0032410 | negative regulation of transporter activity | 3.673690e-3 |
GO:0060136 | embryonic process involved in female pregnancy | 3.675018e-3 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 3.680023e-3 |
GO:0035315 | hair cell differentiation | 3.680023e-3 |
GO:0009719 | response to endogenous stimulus | 3.693041e-3 |
GO:0010627 | regulation of intracellular protein kinase cascade | 3.700800e-3 |
GO:0007527 | adult somatic muscle development | 3.830734e-3 |
GO:0071346 | cellular response to interferon-gamma | 3.844137e-3 |
GO:0050687 | negative regulation of defense response to virus | 3.884056e-3 |
GO:0046381 | CMP-N-acetylneuraminate metabolic process | 3.884056e-3 |
GO:0006892 | post-Golgi vesicle-mediated transport | 3.896127e-3 |
GO:0060026 | convergent extension | 3.968158e-3 |
GO:0010595 | positive regulation of endothelial cell migration | 3.977992e-3 |
GO:0009060 | aerobic respiration | 4.007917e-3 |
GO:0046951 | ketone body biosynthetic process | 4.012600e-3 |
GO:0048741 | skeletal muscle fiber development | 4.012766e-3 |
GO:0034501 | protein localization to kinetochore | 4.028168e-3 |
GO:0006939 | smooth muscle contraction | 4.046004e-3 |
GO:0010632 | regulation of epithelial cell migration | 4.097023e-3 |
GO:0007219 | Notch signaling pathway | 4.149200e-3 |
GO:0042127 | regulation of cell proliferation | 4.157203e-3 |
GO:0010226 | response to lithium ion | 4.167597e-3 |
GO:0007059 | chromosome segregation | 4.172303e-3 |
GO:0021772 | olfactory bulb development | 4.205281e-3 |
GO:0045047 | protein targeting to ER | 4.348488e-3 |
GO:0045589 | regulation of regulatory T cell differentiation | 4.357246e-3 |
GO:0010868 | negative regulation of triglyceride biosynthetic process | 4.357246e-3 |
GO:0021988 | olfactory lobe development | 4.443703e-3 |
GO:0019395 | fatty acid oxidation | 4.486256e-3 |
GO:0051647 | nucleus localization | 4.559011e-3 |
GO:0051930 | regulation of sensory perception of pain | 4.573989e-3 |
GO:0045165 | cell fate commitment | 4.592356e-3 |
GO:0010046 | response to mycotoxin | 4.683893e-3 |
GO:0034341 | response to interferon-gamma | 4.747454e-3 |
GO:0010624 | regulation of Schwann cell proliferation | 4.769191e-3 |
GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment | 4.832920e-3 |
GO:0071900 | regulation of protein serine/threonine kinase activity | 4.988916e-3 |
GO:0000387 | spliceosomal snRNP assembly | 5.056612e-3 |
GO:0048520 | positive regulation of behavior | 5.176833e-3 |
GO:0045956 | positive regulation of calcium ion-dependent exocytosis | 5.197638e-3 |
GO:0015850 | organic alcohol transport | 5.214314e-3 |
GO:0009893 | positive regulation of metabolic process | 5.253643e-3 |
GO:0033313 | meiotic cell cycle checkpoint | 5.253922e-3 |
GO:0010996 | response to auditory stimulus | 5.253922e-3 |
GO:0042138 | meiotic DNA double-strand break formation | 5.253922e-3 |
GO:0006427 | histidyl-tRNA aminoacylation | 5.253922e-3 |
GO:0010085 | polarity specification of proximal/distal axis | 5.253922e-3 |
GO:0009786 | regulation of asymmetric cell division | 5.253922e-3 |
GO:0051726 | regulation of cell cycle | 5.261790e-3 |
GO:0046504 | glycerol ether biosynthetic process | 5.296863e-3 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 5.306787e-3 |
GO:0043549 | regulation of kinase activity | 5.390671e-3 |
GO:0060745 | mammary gland branching involved in pregnancy | 5.401975e-3 |
GO:0060523 | prostate epithelial cord elongation | 5.401975e-3 |
GO:0042310 | vasoconstriction | 5.451202e-3 |
GO:2000151 | negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | 5.519155e-3 |
GO:2000162 | negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis | 5.519155e-3 |
GO:2000166 | negative regulation of planar cell polarity pathway involved in pericardium morphogenesis | 5.519155e-3 |
GO:2000168 | negative regulation of planar cell polarity pathway involved in neural tube closure | 5.519155e-3 |
GO:2000164 | negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis | 5.519155e-3 |
GO:2000149 | negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis | 5.519155e-3 |
GO:0010625 | positive regulation of Schwann cell proliferation | 5.519155e-3 |
GO:2000055 | positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 5.519155e-3 |
GO:0061310 | canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development | 5.519155e-3 |
GO:0071877 | regulation of adrenergic receptor signaling pathway | 5.519155e-3 |
GO:0090007 | regulation of mitotic anaphase | 5.519155e-3 |
GO:0001867 | complement activation, lectin pathway | 5.588589e-3 |
GO:0001990 | regulation of systemic arterial blood pressure by hormone | 5.608174e-3 |
GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway | 5.621866e-3 |
GO:0007519 | skeletal muscle tissue development | 5.789944e-3 |
GO:0071241 | cellular response to inorganic substance | 5.830599e-3 |
GO:0002572 | pro-T cell differentiation | 5.880753e-3 |
GO:0014065 | phosphatidylinositol 3-kinase cascade | 5.891349e-3 |
GO:0070647 | protein modification by small protein conjugation or removal | 5.914602e-3 |
GO:0060736 | prostate gland growth | 5.963103e-3 |
GO:0048178 | negative regulation of hepatocyte growth factor biosynthetic process | 5.986945e-3 |
GO:0043163 | cell envelope organization | 5.986945e-3 |
GO:0009415 | response to water | 6.026968e-3 |
GO:0021675 | nerve development | 6.056879e-3 |
GO:0008347 | glial cell migration | 6.183115e-3 |
GO:0072249 | metanephric glomerular visceral epithelial cell development | 6.183721e-3 |
GO:0048677 | axon extension involved in regeneration | 6.183721e-3 |
GO:0072274 | metanephric glomerular basement membrane development | 6.183721e-3 |
GO:0045769 | negative regulation of asymmetric cell division | 6.183721e-3 |
GO:0006742 | NADP catabolic process | 6.183721e-3 |
GO:0008285 | negative regulation of cell proliferation | 6.354256e-3 |
GO:0009743 | response to carbohydrate stimulus | 6.405839e-3 |
GO:0060839 | endothelial cell fate commitment | 6.441205e-3 |
GO:0000154 | rRNA modification | 6.496650e-3 |
GO:0006991 | response to sterol depletion | 6.496650e-3 |
GO:0043201 | response to leucine | 6.771330e-3 |
GO:0030823 | regulation of cGMP metabolic process | 6.858113e-3 |
GO:0046907 | intracellular transport | 6.868927e-3 |
GO:0008202 | steroid metabolic process | 6.899027e-3 |
GO:0043010 | camera-type eye development | 6.918969e-3 |
GO:0043408 | regulation of MAPKKK cascade | 7.039301e-3 |
GO:0060538 | skeletal muscle organ development | 7.048647e-3 |
GO:0002903 | negative regulation of B cell apoptosis | 7.112126e-3 |
GO:0006732 | coenzyme metabolic process | 7.157708e-3 |
GO:0016073 | snRNA metabolic process | 7.166802e-3 |
GO:2000611 | positive regulation of thyroid hormone generation | 7.186096e-3 |
GO:0061072 | iris morphogenesis | 7.186096e-3 |
GO:0051301 | cell division | 7.252641e-3 |
GO:0006563 | L-serine metabolic process | 7.304761e-3 |
GO:0009414 | response to water deprivation | 7.366111e-3 |
GO:0060836 | lymphatic endothelial cell differentiation | 7.393992e-3 |
GO:0010453 | regulation of cell fate commitment | 7.422858e-3 |
GO:0008206 | bile acid metabolic process | 7.516811e-3 |
GO:0010604 | positive regulation of macromolecule metabolic process | 7.587818e-3 |
GO:0050672 | negative regulation of lymphocyte proliferation | 7.592383e-3 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 7.742696e-3 |
GO:0000239 | pachytene | 7.795090e-3 |
GO:0006911 | phagocytosis, engulfment | 7.805515e-3 |
GO:0016192 | vesicle-mediated transport | 7.891011e-3 |
GO:0090245 | axis elongation involved in somitogenesis | 7.948827e-3 |
GO:0035519 | protein K29-linked ubiquitination | 7.948827e-3 |
GO:0021874 | Wnt receptor signaling pathway involved in forebrain neuroblast division | 7.948827e-3 |
GO:0010872 | regulation of cholesterol esterification | 8.093987e-3 |
GO:2000177 | regulation of neural precursor cell proliferation | 8.293502e-3 |
GO:0032277 | negative regulation of gonadotropin secretion | 8.418236e-3 |
GO:0046395 | carboxylic acid catabolic process | 8.445262e-3 |
GO:0050432 | catecholamine secretion | 8.456953e-3 |
GO:0003044 | regulation of systemic arterial blood pressure mediated by a chemical signal | 8.514495e-3 |
GO:0030335 | positive regulation of cell migration | 8.562473e-3 |
GO:0042093 | T-helper cell differentiation | 8.761945e-3 |
GO:0042537 | benzene-containing compound metabolic process | 8.763793e-3 |
GO:0007520 | myoblast fusion | 8.802881e-3 |
GO:0009725 | response to hormone stimulus | 8.835525e-3 |
GO:0048268 | clathrin coat assembly | 8.867346e-3 |
GO:0008209 | androgen metabolic process | 8.867743e-3 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 9.000720e-3 |
GO:0000768 | syncytium formation by plasma membrane fusion | 9.204113e-3 |
GO:0019264 | glycine biosynthetic process from serine | 9.263579e-3 |
GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport | 9.263579e-3 |
GO:0046325 | negative regulation of glucose import | 9.329843e-3 |
GO:2000147 | positive regulation of cell motility | 9.438584e-3 |
GO:0050868 | negative regulation of T cell activation | 9.467773e-3 |
GO:0032782 | bile acid secretion | 9.518678e-3 |
GO:0003096 | renal sodium ion transport | 9.518678e-3 |
GO:0010725 | regulation of primitive erythrocyte differentiation | 9.518678e-3 |
GO:0030890 | positive regulation of B cell proliferation | 9.615354e-3 |
GO:0071400 | cellular response to oleic acid | 9.629056e-3 |
GO:0009181 | purine ribonucleoside diphosphate catabolic process | 9.645248e-3 |
GO:0030850 | prostate gland development | 9.703279e-3 |
GO:0034622 | cellular macromolecular complex assembly | 9.725286e-3 |
GO:0043405 | regulation of MAP kinase activity | 9.745493e-3 |
GO:0060712 | spongiotrophoblast layer development | 9.791820e-3 |
GO:0030334 | regulation of cell migration | 9.793249e-3 |
GO:0070664 | negative regulation of leukocyte proliferation | 9.861727e-3 |
GO:0045636 | positive regulation of melanocyte differentiation | 9.861999e-3 |
GO:0007501 | mesodermal cell fate specification | 9.861999e-3 |
GO:0009888 | tissue development | 9.864570e-3 |
GO:2000106 | regulation of leukocyte apoptosis | 9.879432e-3 |
GO:0046463 | acylglycerol biosynthetic process | 9.892921e-3 |
GO:0006901 | vesicle coating | 9.946601e-3 |
GO:0000087 | M phase of mitotic cell cycle | 9.949952e-3 |
GO:0001656 | metanephros development | 9.986168e-3 |
GO:0009607 | response to biotic stimulus | 1.025194e-2 |
GO:0034383 | low-density lipoprotein particle clearance | 1.044251e-2 |
GO:0072144 | glomerular mesangial cell development | 1.046435e-2 |
GO:0060603 | mammary gland duct morphogenesis | 1.046658e-2 |
GO:0071577 | zinc ion transmembrane transport | 1.048432e-2 |
GO:0031122 | cytoplasmic microtubule organization | 1.048432e-2 |
GO:0070528 | protein kinase C signaling cascade | 1.049588e-2 |
GO:0045338 | farnesyl diphosphate metabolic process | 1.049588e-2 |
GO:0006269 | DNA replication, synthesis of RNA primer | 1.049588e-2 |
GO:0018342 | protein prenylation | 1.049588e-2 |
GO:0060788 | ectodermal placode formation | 1.060782e-2 |
GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity | 1.065266e-2 |
GO:0006298 | mismatch repair | 1.066387e-2 |
GO:0032703 | negative regulation of interleukin-2 production | 1.066997e-2 |
GO:0060596 | mammary placode formation | 1.069175e-2 |
GO:0031529 | ruffle organization | 1.069175e-2 |
GO:0006725 | cellular aromatic compound metabolic process | 1.087637e-2 |
GO:0071702 | organic substance transport | 1.096462e-2 |
GO:0015840 | urea transport | 1.099406e-2 |
GO:0002691 | regulation of cellular extravasation | 1.099406e-2 |
GO:2000639 | negative regulation of SREBP-mediated signaling pathway | 1.106139e-2 |
GO:2000346 | negative regulation of hepatocyte proliferation | 1.106139e-2 |
GO:0048627 | myoblast development | 1.106139e-2 |
GO:0030826 | regulation of cGMP biosynthetic process | 1.118379e-2 |
GO:0044320 | cellular response to leptin stimulus | 1.118846e-2 |
GO:0061324 | canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation | 1.118846e-2 |
GO:0006413 | translational initiation | 1.119403e-2 |
GO:0042421 | norepinephrine biosynthetic process | 1.128201e-2 |
GO:0045737 | positive regulation of cyclin-dependent protein kinase activity | 1.140938e-2 |
GO:0007494 | midgut development | 1.140981e-2 |
GO:0006887 | exocytosis | 1.141227e-2 |
GO:0007126 | meiosis | 1.147841e-2 |
GO:0034441 | plasma lipoprotein particle oxidation | 1.149817e-2 |
GO:0042221 | response to chemical stimulus | 1.150060e-2 |
GO:0046496 | nicotinamide nucleotide metabolic process | 1.150483e-2 |
GO:0050688 | regulation of defense response to virus | 1.155242e-2 |
GO:0019220 | regulation of phosphate metabolic process | 1.161067e-2 |
GO:0051412 | response to corticosterone stimulus | 1.167377e-2 |
GO:0007569 | cell aging | 1.179443e-2 |
GO:0035067 | negative regulation of histone acetylation | 1.186750e-2 |
GO:0042180 | cellular ketone metabolic process | 1.201457e-2 |
GO:0007160 | cell-matrix adhesion | 1.212181e-2 |
GO:0055114 | oxidation-reduction process | 1.220730e-2 |
GO:0007141 | male meiosis I | 1.239446e-2 |
GO:0060914 | heart formation | 1.242752e-2 |
GO:0061098 | positive regulation of protein tyrosine kinase activity | 1.242876e-2 |
GO:0045576 | mast cell activation | 1.243372e-2 |
GO:0090280 | positive regulation of calcium ion import | 1.248157e-2 |
GO:0002669 | positive regulation of T cell anergy | 1.272685e-2 |
GO:0070527 | platelet aggregation | 1.293569e-2 |
GO:0009653 | anatomical structure morphogenesis | 1.295180e-2 |
GO:0042594 | response to starvation | 1.308889e-2 |
GO:0051409 | response to nitrosative stress | 1.312589e-2 |
GO:0018027 | peptidyl-lysine dimethylation | 1.312613e-2 |
GO:0046697 | decidualization | 1.312881e-2 |
GO:0010829 | negative regulation of glucose transport | 1.313660e-2 |
GO:0015810 | aspartate transport | 1.317705e-2 |
GO:0042176 | regulation of protein catabolic process | 1.329675e-2 |
GO:2001013 | epithelial cell proliferation involve in renal tubule morphogenesis | 1.349201e-2 |
GO:0072160 | nephron tubule epithelial cell differentiation | 1.349201e-2 |
GO:0061136 | regulation of proteasomal protein catabolic process | 1.352100e-2 |
GO:0015938 | coenzyme A catabolic process | 1.359230e-2 |
GO:0035106 | operant conditioning | 1.359230e-2 |
GO:0046464 | acylglycerol catabolic process | 1.377332e-2 |
GO:0001708 | cell fate specification | 1.390153e-2 |
GO:0042443 | phenylethylamine metabolic process | 1.408534e-2 |
GO:0033342 | negative regulation of collagen binding | 1.408534e-2 |
GO:0010571 | positive regulation of DNA replication involved in S phase | 1.408534e-2 |
GO:0015870 | acetylcholine transport | 1.408978e-2 |
GO:0051272 | positive regulation of cellular component movement | 1.409071e-2 |
GO:0030516 | regulation of axon extension | 1.412757e-2 |
GO:0048869 | cellular developmental process | 1.413096e-2 |
GO:0042058 | regulation of epidermal growth factor receptor signaling pathway | 1.415252e-2 |
GO:0033315 | meiotic cell cycle DNA replication checkpoint | 1.423275e-2 |
GO:0031118 | rRNA pseudouridine synthesis | 1.423275e-2 |
GO:0000236 | mitotic prometaphase | 1.423275e-2 |
GO:0010032 | meiotic chromosome condensation | 1.423275e-2 |
GO:0001975 | response to amphetamine | 1.423888e-2 |
GO:0051338 | regulation of transferase activity | 1.439017e-2 |
GO:0032147 | activation of protein kinase activity | 1.443119e-2 |
GO:0010746 | regulation of plasma membrane long-chain fatty acid transport | 1.445475e-2 |
GO:0043496 | regulation of protein homodimerization activity | 1.449380e-2 |
GO:0055015 | ventricular cardiac muscle cell development | 1.453688e-2 |
GO:0014070 | response to organic cyclic compound | 1.462250e-2 |
GO:0051216 | cartilage development | 1.475491e-2 |